Debris from the proximal filter of the Sentinel system, including valve tissue, arterial wall with acute thrombus, calcification, and myocardium (Photo Credit: Aloke Finn) In a small, prospective ...
The Sentinel cerebral protection system (Boston Scientific) was infrequently used during TAVI procedures performed in Germany over a recent 3-year span, and it was not associated with less clinical ...
Please provide your email address to receive an email when new articles are posted on . The Emboliner embolic protection device showed noninferiority vs. the Sentinel device during TAVR. The new ...
Please provide your email address to receive an email when new articles are posted on . Routine cerebral embolic protection did not reduce stroke in patients undergoing transcatheter aortic valve ...
In the first head-to-head comparison of two devices intended to protect against stroke in patients undergoing transcatheter aortic valve replacement (TAVR), the investigational Emboliner device ...
SANTA ROSA, Calif.--(BUSINESS WIRE)--Claret Medical® today announced that it has received regulatory clearance from the U.S. Food and Drug Administration (FDA) for the Sentinel™ Cerebral Protection ...
MARLBOROUGH, Mass., Sept. 17, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE:BSX) has announced results from the PROTECTED TAVR clinical trial evaluating the SENTINEL™ Cerebral Protection ...
SILVER SPRING, MD — Unanimously disappointed with the end point used to determine clinical benefit, advisors to the US Food and Drug Administration (FDA) agreed the Sentinel Cerebral Protection System ...
SANTA ROSA, Calif.--(BUSINESS WIRE)--Claret Medical® today announced that in an open public hearing of the FDA’s Circulatory System Devices Panel last week, virtually all panel members recommended the ...
A device designed to remove embolic material—fragments of tissue that can be released into the bloodstream during transcatheter aortic valve replacement (TAVR)—did not result in a reduction in the ...
CHICAGO -- Routine use of devices to prevent cerebral emboli during transcatheter aortic valve implantation (TAVI) did not prevent strokes, a large randomized trial showed. Incidence of stroke within ...
Use of the Sentinel (Boston Scientific) embolic protection device is highly variable and its ability to limit cerebral injury modest at best, a TVT Registry study suggests. The primary analysis, using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results